Last updated: May 23, 2026
Slynd (drospirenone) Supplier Map: Who Manufactures Active Drug, Fill-Finish, and Key Components in the US Market
Slynd’s US supply chain centers on branded drospirenone tablets produced under FDA-licensed facilities and distributed through branded drug channels. Primary “supplier” roles in the market fall into three buckets: (1) drug-substance and tablet manufacturing sites, (2) packaging and labeling contractors tied to the FDA-registered product, and (3) logistics distributors that handle brand distribution.
No complete, auditable supplier roster (manufacturers, packagers, and component sources) can be produced from the information provided in the prompt alone.
What companies manufacture Slynd (drospirenone) tablets in the US?
Answer (data-backed): Not available from the prompt.
Slynd is a prescription oral contraceptive containing drospirenone. The identities of the FDA-registered manufacturers and packagers are typically confirmed via the Orange Book product listing and FDA drug-label “Manufactured for/By” sections, plus inspection histories tied to the NDA. Those specific entity names are not included in the provided input.
Who is listed as manufacturer, packager, or labeler on the Slynd label?
Answer (data-backed): Not available from the prompt.
The drug label generally lists:
- manufacturer of the drug product (tablets)
- packager and/or relabeler (if different)
- marketing authorization holder (brand owner)
None of these are provided in the prompt.
Are there multiple manufacturing sites for Slynd?
Answer (data-backed): Not available from the prompt.
Multi-site supply is common for oral solids, but it must be validated via FDA listings and label/manufacturing site data.
What is the Orange Book status of Slynd and what does it imply about supply?
Answer (data-backed): Not available from the prompt.
Orange Book status determines patent expiry risk and the likelihood of authorized generics or alternative manufacturing supply. But without the Orange Book listing details (NDA number, listed patents, and FDA manufacturing/labeler entries), “supplier” conclusions cannot be made.
Does Slynd have authorized generic or approved alternatives that change supplier relationships?
Answer (data-backed): Not available from the prompt.
If authorized generics exist, they can shift manufacturing volume to different contract development and manufacturing organizations (CDMOs). That requires confirmation through Orange Book and FDA approvals for ANDAs/505(b)(2).
Who supplies drospirenone API for Slynd?
Answer (data-backed): Not available from the prompt.
API suppliers are typically not fully named in public product labels. API source can be inferred from DMFs, but it must be pulled from FDA DMF listings or supply-chain disclosures tied to the NDA. None is present in the prompt.
Which fill-finish and packaging contractors support Slynd blistering and bottling?
Answer (data-backed): Not available from the prompt.
Oral contraceptives are commonly supplied as:
- blister packs (often require specific packaging line validation)
- unit-dose bottles with desiccant control
Packaging contractor names must be confirmed from the label’s manufacturing/packaging sections and FDA facility registrations.
Are there different suppliers by dosage strength or package size for Slynd?
Answer (data-backed): Not available from the prompt.
If multiple strengths or pack configurations exist, each can map to different packaging lines and sometimes different product manufacturing sites.
How do Slynd supply chain constraints affect generic entry and Paragraph IV risk?
Answer (data-backed): Not available from the prompt.
Supply-chain bottlenecks influence launch timelines but do not replace patent and regulatory entry analysis. That analysis requires NDA/Orange Book and litigation/ANDA filing data not provided here.
Key Takeaways
- “Supplier” for Slynd can mean drug-product manufacturer, packager/labeler, or API supplier.
- None of the required public identifiers (label manufacturer/packager names, Orange Book NDA listing, DMF/API source listings) are included in the prompt, so a complete supplier map cannot be produced.
FAQs
-
Who is the marketing authorization holder for Slynd in the US?
Not available from the prompt.
-
What NDA number corresponds to Slynd?
Not available from the prompt.
-
Which FDA-registered facilities manufacture and package Slynd tablets?
Not available from the prompt.
-
Is drospirenone API sourced from DMFs supporting the Slynd NDA, and which DMF holders?
Not available from the prompt.
-
Do packaging configurations (blisters vs bottles) use different contract packaging sites for Slynd?
Not available from the prompt.
References
No sources were cited because the prompt did not include any verifiable supplier identifiers, and providing a supplier list without citations would not meet the data-quality constraints.
